Literature DB >> 16894191

A granule cell neuron-associated JC virus variant has a unique deletion in the VP1 gene.

Xin Dang1, Igor J Koralnik.   

Abstract

The human polyomavirus JC (JCV) typically infects glial cells and is the aetiological agent of progressive multifocal leukoencephalopathy (PML), which occurs in immunosuppressed individuals. The full-length sequence of a granule cell neuron-tropic JCV variant, JCV(GCN1), associated with lytic infection of granule cell neurons and cerebellar atrophy in a human immunodeficiency virus-infected patient with PML was determined and compared with the sequence of the JCV isolate from the classic PML lesions present in the hemispheric white matter of the same individual (JCV(HWM)). A unique deletion was found in the C terminus of the VP1 gene of JCV(GCN1), which encodes the major capsid protein, resulting in a frame shift and a total change of the C-terminal amino acid sequence of this protein. This deletion was not present in JCV(HWM), suggesting that this mutation may be instrumental in facilitating entry or replication of JCV into granule cell neurons.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16894191     DOI: 10.1099/vir.0.81945-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  32 in total

Review 1.  Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis.

Authors:  Chen S Tan; Igor J Koralnik
Journal:  Lancet Neurol       Date:  2010-04       Impact factor: 44.182

2.  JC virus infection of the brain.

Authors:  A K Bag; J K Curé; P R Chapman; G H Roberson; R Shah
Journal:  AJNR Am J Neuroradiol       Date:  2010-03-18       Impact factor: 3.825

Review 3.  PML diagnostic criteria: consensus statement from the AAN Neuroinfectious Disease Section.

Authors:  Joseph R Berger; Allen J Aksamit; David B Clifford; Larry Davis; Igor J Koralnik; James J Sejvar; Russell Bartt; Eugene O Major; Avindra Nath
Journal:  Neurology       Date:  2013-04-09       Impact factor: 9.910

4.  JC virus granule cell neuronopathy is associated with VP1 C terminus mutants.

Authors:  Xin Dang; Jose E Vidal; Augusto C Penalva de Oliveira; David M Simpson; Susan Morgello; Jonathan H Hecht; Long H Ngo; Igor J Koralnik
Journal:  J Gen Virol       Date:  2011-09-21       Impact factor: 3.891

5.  Naturally arising strains of polyomaviruses with severely attenuated microRNA expression.

Authors:  Chun Jung Chen; James M Burke; Rodney P Kincaid; Kristopher D Azarm; Noel Mireles; Janet S Butel; Christopher S Sullivan
Journal:  J Virol       Date:  2014-08-20       Impact factor: 5.103

Review 6.  Diagnosis and Treatment of Progressive Multifocal Leukoencephalopathy Associated with Multiple Sclerosis Therapies.

Authors:  Eric M L Williamson; Joseph R Berger
Journal:  Neurotherapeutics       Date:  2017-10       Impact factor: 7.620

7.  Simian Virus 40 Infection in the Spinal Cord of Simian Immunodeficiency Virus-Immunosuppressed Rhesus Macaques.

Authors:  Saravanan Kaliyaperumal; Christian Wüthrich; Susan V Westmoreland; Igor J Koralnik
Journal:  J Neuropathol Exp Neurol       Date:  2015-11       Impact factor: 3.685

8.  Frequent infection of neurons by SV40 virus in SIV-infected macaque monkeys with progressive multifocal leukoencephalopathy and meningoencephalitis.

Authors:  Saravanan Kaliyaperumal; Xin Dang; Christian Wuethrich; Heather L Knight; Christine Pearson; John MacKey; Keith G Mansfield; Igor J Koralnik; Susan V Westmoreland
Journal:  Am J Pathol       Date:  2013-10-01       Impact factor: 4.307

9.  The 50th birthday of progressive multifocal leukoencephalopathy: New insights into pathogenesis.

Authors:  Kenneth L Tyler
Journal:  Ann Neurol       Date:  2008-10       Impact factor: 10.422

10.  JCV GCN in a natalizumab-treated MS patient is associated with mutations of the VP1 capsid gene.

Authors:  Shruti P Agnihotri; Xin Dang; Jonathan L Carter; Terry D Fife; Evelyn Bord; Stephanie Batson; Igor J Koralnik
Journal:  Neurology       Date:  2014-07-18       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.